Genix Pharmaceuticals Corporation reported earnings results for the second quarter and six months ended April 30, 2023. For the second quarter, the company reported revenue was CAD 0.008083 million. Net loss was CAD 0.234018 million compared to CAD 0.227517 million a year ago.
For the six months, revenue was CAD 0.009665 million. Net loss was CAD 0.461055 million compared to CAD 0.566013 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.